Support Services Directory
Recent advancements in cancer treatments have revolutionized cancer care. The use of genetic mutations to guide therapy, and continued innovations in immunotherapies, targeted drugs, radiation, and chemotherapy have improved patients’ health outcomes and quality of life.1
The 5-year relative survival rate for all cancers diagnosed between 2005 and 2011 increased to 69%, a significant increase from the 49% rate for cancer diagnosed between 1975 and 1977.2 The improvement in survival rates can be attributed to the current trends of earlier diagnosis and continuing innovations in cancer therapies.2
Nevertheless, cancer remains a leading cause of death in the United States.1 According to the American Cancer Society, more than 15 million patients with cancer were living in the United States in 2016, and that number is expected to exceed 20 million in 2026.3
The United States’ commitment to accelerating cancer research was highlighted in 2016, with Vice President Joe Biden’s launch of the Cancer Moonshot initiative, which aims to make more therapies available to more patients, while improving cancer prevention and early diagnosis, with the ultimate goal of curing cancer. Indeed, the oncology drug pipeline continues to have a large share of the drug pipeline, as evident by its 63% increase in the past 10 years,4 a trend that is bound to accelerate with the Cancer Moonshot initiative in the future.
Yet this innovation comes with a cost, and much of the cost burden today has been shifted to patients, making affordability and access key concerns for patients with cancer. The global cost of cancer therapies and supportive care drugs reached $107 billion in 2015, which is projected to exceed $150 billion by 2020.4
Increasing costs have prompted insurance companies to shift a larger portion of care to patients in the form of high premiums, deductibles, and copayments, resulting in significantly high out-of-pocket expenses for patients. This financial toxicity is leading to lack of adherence, which has been shown to worsen survival outcomes.5 Young adults, minorities, and lower-income Americans are especially vulnerable to the harmful effects of financial toxicity.5,6
Cost discussions between patients and physicians are becoming an important part of informed decision-making when selecting cancer treatments, and the National Comprehensive Cancer Network encourages these discussions.7
Many support programs are available today for patients with cancer who are in need of financial assistance. The following directory provides an overview of the many patient support services provided by pharmaceutical companies, nonprofit organizations and foundations, and federal programs.
- Dizon DS, Krilov L, Cohen E, et al. Clinical cancer advances 2016: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2016;34:987-1011.
- American Cancer Society. Cancer facts and figures 2016. 2016. www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf. Accessed December 12, 2016.
- American Cancer Society. Cancer treatment and survivorship facts and figures 2016-2017. 2016. www.cancer.org/acs/groups/content/@research/documents/document/acspc-048074.pdf. Accessed December 12, 2016.
- IMS Health. Global oncology trend report: a review of 2015 and outlook to 2020. 2015. www.imshealth.com/en/thought-leadership/quintiles-ims-institute/reports/global-oncology-trend-report-a-review-of-2015-and-outlook-to-2020#download-exhibits. Accessed December 13, 2016.
- Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27:80-149.
- Landwehr MS, Watson SE, Macpherson CF, et al. The cost of cancer: a retrospective analysis of the financial impact of cancer on young adults. Cancer Med. 2016;5:863-870.
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) with NCCN Evidence Blocks. www.nccn.org/evidenceblocks/. Accessed December 13, 2016.
American Breast Cancer Foundation
The American Breast Cancer Foundation provides direct financial assistance to uninsured and underserved women and men of all ages for breast cancer screening and diagnostic tests through the Breast Cancer Assistance Program, Community Partnership Program, and the Community Advocacy Program.
American Cancer Society
The American Cancer Society has programs and services to help patients with cancer and their loved ones understand cancer, manage their lives through treatment and recovery, and identify resources for financial assistance.
American Childhood Cancer Organization
The American Childhood Cancer Organization provides programs, information, and awareness for children and adolescents with cancer and their families, to advocate for their needs, and to support research so every child survives and leads a long and healthy life.
The Assistance Fund
The Assistance Fund is a leading nonprofit organization that provides advanced therapies to the underinsured critically or chronically ill population through a range of services, including education and financial aid.
Avon Foundation for Women
The Avon Foundation for Women, through the Avon Breast Health Outreach Program, links medically underserved women to breast health education and screening services. The foundation provides targeted, customized approaches to help low-income, underinsured, and other marginalized populations obtain regular mammograms and clinical breast exams.
CancerCare is a national nonprofit organization that provides free professional support services to patients with cancer and their caregivers. CancerCare programs, which include counseling, education, financial and copayment assistance, and practical help, are provided by trained oncology social workers. CancerCare’s financial assistance programs provide limited financial assistance for cancer-related costs. The CancerCare Co-Payment Assistance Foundation helps patients afford insurance copayments for chemotherapy and targeted treatments.
Cancer Financial Assistance Coalition
The Cancer Financial Assistance Coalition is a group of national organizations that provide financial help to patients with cancer. The Cancer Financial Assistance Coalition provides a searchable database of financial resources available to patients in need.
Cancer Support Community
The Cancer Support Community is an international nonprofit organization that is dedicated to providing support, education, and hope to individuals affected by cancer. The Cancer Support Community offers a menu of personalized services and education. These support services are available through a network of professionally led, community-based centers, hospitals, community oncology practices, and online resources.
Good Days, formerly known as the Chronic Disease Fund, provides assistance to underinsured patients who are diagnosed with chronic or life-altering diseases (including cancer) so that they get access to the medications they need.
The HealthWell Foundation is an independent, nonprofit organization that provides financial assistance to eligible individuals to cover coinsurance, copayments, insurance premiums, and deductibles for certain medications and therapies.
Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society’s patient financial support program provides limited financial assistance (such as financial support toward insurance copayments, insurance premium costs, and certain testing costs) to patients diagnosed with a blood cancer (eg, leukemia, lymphoma, or multiple myeloma) and with significant financial needs to help defray treatment-related expenses.
National Children’s Cancer Society
The National Children’s Cancer Society seeks to improve the quality of life for children with cancer and their families by providing financial and in-kind assistance, advocacy, support services, and education.
National Foundation for Transplants
The National Foundation for Transplants provides fundraising assistance for patients needing organ and tissue transplants, including bone marrow and stem-cell transplants.
National Organization for Rare Disorders
The National Organization for Rare Disorders is a federation of patient organizations that are dedicated to helping patients with rare orphan diseases and assisting the organizations that serve them. The National Organization for Rare Disorders is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.
NeedyMeds, a 501(c)(3) nonprofit organization, is an information resource on available patient assistance programs that help individuals who cannot afford medications or other healthcare costs.
Partnership for Prescription Assistance
The Partnership for Prescription Assistance helps qualifying patients without prescription drug coverage get the medication they need by connecting them to patient assistance programs. This organization offers access to more than 475 public and private programs, including 200 pharmaceutical company programs.
Patient Access Network Foundation
The Patient Access Network Foundation provides financial support for out-of-pocket costs associated with a wide range of medications to treat a number of chronic or life-threatening conditions, including cancer.
Patient Advocate Foundation Co-Pay Relief Program
The Patient Advocate Foundation Co-Pay Relief Program provides direct financial support to financially and medically eligible patients, including Medicare Part D beneficiaries. These may include out-of-pocket costs associated with healthcare insurance copayments, coinsurance, and deductibles.
Patient Services, Inc
Patient Services, Inc, is a nonprofit organization dedicated to providing health insurance premium assistance, pharmacy copayment assistance, and copayment waiver assistance for patients with chronic illnesses, including cancer.
RxAssist, through their online Patient Assistance Program Center, provides a comprehensive database of patient assistance programs offered by pharmaceutical companies as well as other tools and resources to manage their medication costs.
RxHope is a web-based patient assistance resource that helps patients obtain free or low-cost prescription medications. RxHope has program descriptions and downloadable applications for prescription assistance programs for specific medications.
Rx Outreach is a nonprofit charity that provides access to affordable medications. Rx Outreach offers more than 600 medications through their mail-order pharmacy to all 50 states, Puerto Rico, and the Virgin Islands.
(National Council on Aging)
BenefitsCheckUp helps individuals aged >55 years find support programs that may cover some of their prescription drug costs and other healthcare expenses.
(Social Security Administration)
Social Security provides benefits to patients with serious medical conditions that meet disability standards. Compassionate Allowances is a means for Social Security to quickly identify medical conditions that qualify for benefits under the Listing of Impairments based on minimal objective medical information and target them for allowances.
(Social Security Administration)
Extra Help is a Social Security program that provides financial assistance to eligible Medicare beneficiaries with their Medicare prescription drug plan costs such as monthly premiums, annual deductibles, and prescription copays. Extra Help is estimated to be worth about $4000 annually. To be eligible for Extra Help, an individual must receive Medicare, have limited resources and income, and reside in 1 of the 50 states or in the District of Columbia.
Genetic and Rare Diseases Information Center
(Office of Rare Diseases Research, National Institutes of Health)
The National Institutes of Health (NIH)’s Office of Rare Diseases Research maintains an online resource that provides links to several support services, including support and advocacy organizations, financial aid for medical treatment, travel and lodging assistance, and fee-for-service ambulance services.
Hill-Burton Free and Reduced-Cost Health Care
(Health Resources and Services Administration)
800-492-0359 in Maryland
As mandated by the Hill-Burton Act, about 150 healthcare facilities nationwide provide free or reduced-cost care for patients who are unable to pay and to make their services available to all persons residing in the facility’s area. Patients are eligible to apply for Hill-Burton free care if their income is at or below the current Health & Human Services (HHS) Poverty Guidelines, and to reduced-cost care if income is 2 times the HHS Poverty Guidelines.
National Cancer Institute: Organizations That Offer Support Services
The NIH maintains a database of government agencies and national organizations that provide financial assistance to patients with cancer and their families. In addition, it provides information about patient assistance programs.
National Council On Patient Information and Education: Understanding Prescription Assistance Programs
The National Council on Patient Information and Education is a nonprofit multistakeholder coalition that is involved in communicating information on prescription assistance programs to consumers and healthcare professionals.
Amgen Assist 360
Amgen Assist provides support options for insured, uninsured, and underinsured patients through a variety of programs.
Amgen First Step
The Amgen FIRST STEP program helps qualified commercially insured patients cover their deductible, coinsurance, or copay out-of-pocket costs.
Amgen Safety Net Foundation
Amgen’s Safety Net Foundation is a nonprofit patient assistance program designed to assist patients who are uninsured, with limited or no financial resources. Program eligibility is based on US residency, insurance status, and income requirements.
Ariad Patient Access And Support Services
The ARIAD Patient Access and Support (ARIAD PASS) program helps providers and patients afford treatment.
Astellas Xtandi Support Solutions
Xtandi Support Solutions helps providers and patients understand patients’ cost-sharing obligations and the mechanisms that are available to reduce the cost of Xtandi (enzalutamide) for eligible patients. Xtandi is indicated for metastatic castration-resistant prostate cancer. The program includes the Astellas Access Program, which provides free Xtandi to patients who have no health insurance and who qualify for enrollment based on their insurance status and household income, as well as the Xtandi Patient Savings Program for insured patients who have private health insurance but who may not be able to pay their out-of-pocket costs.
AstraZeneca Access 360
AstraZeneca’s Access 360 program is designed to streamline access to the company’s drugs through a variety of support options. Access 360 provides patients, their caregivers and family, and providers with affordability and reimbursement support in obtaining their medications.
Az&Me AstraZeneca Prescription Savings Program
The AZ&Me AstraZeneca Prescription Savings Program provides AstraZeneca medications at no cost to individuals without health insurance and to Medicare Part D beneficiaries. This program provides AstraZeneca medications to low-income patients through qualifying facilities, such as disproportionate-share hospitals, community health centers, community free clinics, central-fill pharmacies, and charitable pharmacy programs.
This free support program provides patients with financial assistance options and with information about their therapy. This program supplies patients with Medicare, Medicaid, and military insurance information about financial assistance options that may be available through independent charitable organizations, and qualified underinsured or uninsured patients may be eligible for up to 12 months of free drugs.
Bayer $0 Co-Pay Program
The $0 Co-Pay Program allows patients to fill their prescription with no out-of-pocket costs for eligible, commercially insured patients. Patients can receive up to $25,000 in savings, with no monthly maximum.
Bayer Xofigo Access Services
Xofigo Access Services provides Xofigo (radium Ra 223 dichloride) free of charge to eligible patients who are uninsured or who are insured but do not have coverage for Xofigo. Patients with private commercial insurance may also be eligible for copay assistance.
Boehringer Ingelheim Solutions Plus
Solutions Plus provides financial assistance for medicine to patients who meet income requirements.
Boehringer Ingelheim Cares Foundation
This program helps US residents in need obtain medications free of charge. Patients must meet certain financial criteria to be eligible for assistance.
Bristol-Myers Squibb Access Support Program
Through its Access Support Program, Bristol-Myers Squibb offers a variety of oncology support options for patients receiving outpatient treatment in the United States and Puerto Rico, and, in certain circumstances, the Virgin Islands.
Bristol-Myers Squibb Oncology Co-Pay Assistance Program
This program is designed to assist with out-of-pocket copays or coinsurance requirements for eligible, commercially insured patients prescribed Bristol-Myers Squibb medications, per FDA-approved indications.
Bristol-Myers Squibb Patient Assistance Foundation
This foundation assists patients who need temporary help paying for BMS medications. To receive temporary help, patients must prove financial hardship and meet other criteria.
Celgene Patient Support
Celgene Patient Support offers healthcare professionals and patients access and reimbursement assistance from a single specialist assigned to each doctor’s office. No matter what the insurance situation, Celgene Patient Support is committed to helping patients access their Celgene medication.
Celgene Commercial Co-pay Program
This program provides up to $10,000 annually to help meet deductible and copay/coinsurance costs. For qualified patients in the program, their cost will be $25 or less, depending on which Celgene drug they are prescribed (assistance not to exceed $10,000). To qualify, patients must have commercial or private insurance and a household income of $100,000 or less.
Celgene Free Medication Program
Patients who do not have insurance coverage for a Celgene medication prescribed by their physicians may be eligible for this program. Patients must meet financial criteria to be eligible for assistance. Program eligibility is based on household income and assets.
Eisai Reimbursement Resources
Through Eisai Reimbursement Resources, patients who are prescribed Eisai pharmaceuticals can find drug-specific resources related to coding, coverage, and reimbursement, as well as a variety of patient assistance services. The resources provided by Eisai Reimbursement Services are drug-specific; therefore, patients and providers are encouraged to visit www.eisaireimbursement.com
and select their prescribed medication for more information on programs specific to that drug.
Endo Pharmaceuticals Patient Assistance Program
The Endo Pharmaceuticals Patient Assistance Program offers free medications to patients who otherwise cannot afford them. Patients must meet financial and other program-specific criteria to be eligible for assistance.
Gelclair Rx Program
A simple one-stop solution for patients with oral mucositis or stomatitis, the program allows patients to receive Gelclair bioadherent oral rinse gel within 24 hours of prescription receipt or confirmation. Most insured patients pay $0 out of pocket for 1 month of therapy.
Genentech Access Solutions
Genentech Access Solutions provides programs and services to help facilitate access to Genentech BioOncology medicines for eligible patients and healthcare professionals. Services include coverage and reimbursement assistance, financial assistance, and resource support, and vary depending on patients’ insurance status.
Genentech Access to Care Foundation
The Genentech Access to Care Foundation helps patients receive medications for free if they do not have a healthcare plan or have been denied coverage for treatment. Patients must have a household-adjusted income of $100,000 or less annually.
Genomic Health Genomic Access Program
The Genomic Access Program assists patients throughout the process of determining insurance coverage and billing for the Oncotype DX test. The program is designed for uninsured and underinsured patients based on financial eligibility.
Gilead Sciences Zydelig Accessconnect
The Zydelig AccessConnect program provides Zydelig (idelalisib) at no charge to eligible patients with no other insurance options.
Zydelig AccessConnect Copay Coupon Card
The Zydelig Copay Coupon Card provides copay assistance for eligible patients with private insurance who need assistance paying for their out-of-pocket medication costs. Most patients will pay no more than $5 per monthly copay.
Zydelig Quickstart Program
The Zydelig QuickStart Program gives eligible patients who have an insurance coverage delay of >5 business days rapid access to a free, 1-time, 30-day supply of Zydelig.
IncyteCARES (Connecting to Access, Reimbursement, Education, and Support) is a suite of services provided by Incyte for patients receiving treatment with Jakafi (ruxolitinib). In addition to patient education, resource support, and helping patients overcome potential insurance barriers, IncyteCARES offers a free medication program, as well as reimbursement and financial assistance options.
IncyteCARES Patient Assistance Program
Uninsured patients or those whose insurance has denied claims for Jakafi treatment may be eligible to receive the drug free of charge via the IncyteCARES Patient Assistance Program, depending on their income.
IncyteCARES Copay/Coinsurance Assistance Program
Patients with private or commercial prescription insurance may be eligible to receive Jakafi for as little as $25 per month, not exceeding $25,000 annually, if they qualify.
Ipsen Cares: Coverage, Access, Reimbursement & Education Support
Ipsen Biopharmaceuticals provides several patient services through its IPSEN CARES: Coverage, Access, Reimbursement & Education Support program to patients who are prescribed Somatuline Depot (lanreotide) for the treatment of neuroendocrine tumors arising from the gastrointestinal tract or the pancreas. IPSEN CARES facilitates access to Somatuline Depot to patients who are insured, underinsured, or uninsured.
Janssen Carepath Savings Program
Janssen CarePath offers one source for patient resources, focused on access, affordability, and treatment support for patients who are prescribed a Janssen cancer medication. The CarePath program also includes patient information about each medication offered, as well as other patient support via the Janssen Learning Center. There are also tools available to help patients stay on track with taking and keeping up with their medication regimens.
Janssen Prescription Assistance
Janssen Prescription Assistance is a resource that provides information about drug-relevant prescription assistance programs for insured, uninsured, and underinsured patients, including state-sponsored or independent financial assistance programs for patients with no coverage, medication-specific savings programs to help with copays and travel costs for patients with private/commercial coverage, and the Low-Income Subsidy program from Medicare for patients with government coverage.
Johnson & Johnson Patient Assistance Foundation
The Johnson & Johnson Patient Assistance Foundation assists patients without adequate financial resources and prescription drug coverage in obtaining free medications donated by the operating companies of Johnson & Johnson. There is 1 application for all agents, and patients may receive free medicines for up to 1 year.
Kyowa Kirin Patient Rx Solutions
Patient Rx Solutions is designed to assist uninsured individuals and those who have no public or private prescription coverage. Kyowa Kirin also offers copay assistance to eligible individuals with private insurance.
Lilly Patientone Access Services
PatientOne addresses financial and coverage issues for qualified uninsured, underinsured, and insured patients who are prescribed a Lilly oncology drug. PatientOne can help provide replacement vials for ongoing therapy to qualified uninsured patients who earn up to 500% of the federal poverty level. In addition, PatientOne provides assistance to insured patients whose claims for a Lilly oncology drug have been denied by their insurer.
Certain eligibility requirements apply. Approved drug requests are conveniently shipped to the physician’s office.
Merck Helps offers a full suite of support services that facilitate access to Merck’s drugs for eligible patients who are unable to afford their Merck medications, regardless of their insurance status.
Merck Patient Assistance Program
The Merck Patient Assistance Program is available to eligible, uninsured patients who may qualify to receive medicine at no cost.
Merck ACT Program
Merck Access Program
The ACT Program and Merck Access Program provide free reimbursement support services to help answer questions related to insurance coverage and reimbursement. The ACT Program also refers patients to the Patient Assistance Program, which provides certain Merck medicines free of charge to eligible patients who do not have insurance coverage. Many Merck medications are included in this program.
Merck Co-Pay Assistance Program
The Merck Co-Pay Assistance Program is available to patients with private health insurance who have been prescribed Keytruda, Intron A for injection, or Sylatron, and meet certain financial requirements.
Merrimack Provyde (Onivyde Access Services)
PROVYDE (Onivyde Access Services) offers patient support services and reimbursement services to facilitate patient access to Onivyde (irinotecan liposome injection). PROVYDE offers a $0 commercial copay program, a patient assistance program, assistance with insurance verification, and help with referrals to independent, nonprofit organizations for federally insured patients and referrals for travel assistance. The program also supports healthcare providers in submitting claims for Onivyde by contacting the payer to confirm that the claim submission was processed correctly, tracking claims until a decision is rendered and relaying results to the provider, and helping the provider’s office troubleshoot any denied or rejected claims.
Midatech Pharma No Coupon, No Copay, No Hassles Program
This program is intended to reduce or eliminate prescription copays by offsetting patient out-of-pocket expenses for qualifying patients, and will be applied automatically to qualified prescriptions at more than 43,000 pharmacies nationwide. Additional paperwork, coupons, or electronic input is not required by patients, healthcare providers, or pharmacists.
Novartis Patient Assistance Now Oncology Program
The Novartis Patient Assistance Now Oncology Program offers quick and easy access to information about the many reimbursement and support programs available to patients. Patients with private insurance or without prescription coverage may be eligible to receive copay discount cards on certain medications.
Novartis Patient Assistance Foundation
The Novartis Patient Assistance Foundation provides assistance to patients who experience financial hardship and who have no third-party insurance coverage for their Novartis medications.
To improve accessibility of services and respond to patients’ needs, Pfizer has combined its existing programs into Pfizer RxPathways, formerly known as Pfizer Helpful Answers. A comprehensive assistance program, Pfizer RxPathways provides eligible patients with a range of support services, including insurance counseling, copay assistance, and access to medicines at no cost or at a savings.
Pfizer RxPathways Patient Assistance Program
The Pfizer RxPathways Patient Assistance Program allows eligible patients who do not have prescription coverage or enough prescription coverage to receive free medications. Patients must meet income requirements that vary by medicine and household size.
Pfizer Co-Pay One Savings Program
To qualify for enrollment in the Pfizer Co-Pay One Savings Program and receive copay assistance, patients must have commercial insurance or pay cash for their medications, not participate in any federal or state healthcare programs, and not have prescription coverage.
Pharmacyclics You&I Support Program
Patients with commercial insurance and who meet certain eligibility requirements pay no more than $10 monthly for Imbruvica (ibrutinib). Eligible patients prescribed Imbruvica for an FDA-approved indication, and who are experiencing an insurance coverage delay of >5 business days, can receive a free 30-day supply of Imbruvica. Under appropriate circumstances, an additional free 30-day supply of Imbruvica may be provided.
Prometheus IV Bolus Proleukin Inpatient Reimbursement Hotline
As part of their commitment to ensure that all eligible patients have access to Proleukin (aldesleukin), the Prometheus IV Bolus Proleukin Inpatient Reimbursement Hotline is staffed with specialists who can help resolve specific access and reimbursement issues for patients and physicians.
Sandoz One Source
Sandoz One Source offers customized support services for patients prescribed Zarxio (filgrastim-sndz), including comprehensive insurance verification; prior authorization support when required; billing and coding information; information on claims tracking, denials, and appeals; and payer policy research. Sandoz One Source also offers financial assistance to eligible patients.
Sanofi Patient Connection
Through the Sanofi Foundation for North America, Sanofi Patient Connection provides medications free of charge to patients who have no insurance coverage or who are considered to be functionally uninsured.
Seattle Genetics Seagen Secure
SeaGen Secure is a comprehensive patient assistance program from Seattle Genetics that offers several resources related to coverage and reimbursement, as well as assistance to patients who cannot afford their prescribed Adcetris (brentuximab vedotin) therapy.
Soltamox Free Prescription Co-Pay Support
This is a free copay assistance program, good for unlimited uses, to qualified patients taking Soltamox (tamoxifen citrate) oral solution. Qualified patients will pay $0 per Soltamox prescription, up to a maximum reimbursement allowance of $100.
Spectrum Therapy Access Resources
Spectrum Pharmaceuticals is committed to providing appropriate patient access to care. Spectrum Therapy Access Resources (STAR) includes a copay assistance program to assist privately insured patients (who meet the STAR eligibility criteria) with copay and coinsurance responsibilities related to certain Spectrum medications. In addition, the STAR program includes a patient assistance program that provides Spectrum medications free of charge to enrolled patients who meet the income, insurance, and citizenship/residency eligibility criteria.
Taiho Oncology Patient Support
The Taiho Oncology Patient Support program provides a range of personalized support services for patients who have been prescribed Lonsurf (trifluridine and tipiracil), including access and reimbursement support, specialty pharmacy prescription coordination, copay support, and a patient assistance program, based on their financial needs and insurance coverage.
Takeda Oncology Ninlaro 1Point
Takeda Oncology’s Ninlaro 1Point offers comprehensive services that can assist patients with the financial burden and other day-to-day needs associated with Ninlaro (ixazomib) treatment, including assisting eligible patients with out-of-pocket costs; helping patients understand their insurance coverage for Ninlaro; providing information about specialty pharmacies that can help patients get Ninlaro; helping patients start therapy as quickly as possible, as directed by their physician; and connecting patients to additional resources, such as legal services, counseling and support programs, emotional support, and transportation assistance.
Takeda Oncology VRAP and VPAP
Takeda Oncology’s Velcade Reimbursement Assistance Program (VRAP) and the Velcade Patient Assistance Program (VPAP) offer a suite of services and resources to practices and eligible patients seeking access to Velcade (bortezomib). Patient services under VRAP and VPAP include financial assistance; navigation through reimbursement processes and concerns; referrals to independent copay foundations; and support and resources for the insured, uninsured, and underinsured.
TOGETHER with TESARO
TOGETHER with TESARO offers solutions to patients for medication access and affordability. Tesaro’s case management team of experts in access and affordability facilitates a seamless process to ensure that patients get the individualized support they need. Currently, the program is offering its services to patients who are prescribed Varubi (rolapitant). TOGETHER with TESARO can offer coverage support, a free first-dose program that provides a single-dose wallet card of Varubi at no cost to patients, and a patient assistance program for eligible uninsured and underinsured patients. Patients may also be eligible for the commercial copay assistance program, which is an independent program that reduces out-of-pocket costs for commercially insured patients and reduces copayments and/or coinsurance to $0 with a $300 per dose cap and no annual maximum allowable benefit. The virtual card can be initiated and utilized by in-office dispensing pharmacies, hospital outpatient clinics, or by the exclusive specialty pharmacy of Tesaro.
Teva Core (Comprehensive Oncology Reimbursement Expertise)
Comprehensive Oncology Reimbursement Expertise supports patients and providers through programs for eligible patients treated in the United States who do not have insurance, cannot afford their out-of-pocket copay costs, or need assistance with reimbursement issues.
Teva Cares Foundation Patient Assistance Program
The foundation offers some medications at no cost to eligible patients who meet certain income and insurance criteria.